drugset / Trial / NCT04622709

Pilot Study of Loop Diuretics Among Individuals Receiving Hemodialysis

NCT04622709

NaSingle-groupOpen-labelTreatment

Summary

Individuals with kidney failure receiving maintenance hemodialysis (HD) have high mortality rates, driven largely by cardiovascular causes. Volume-related factors are critical, modifiable contributors to cardiovascular complications. Reversing volume overload has been shown to improve blood pressure and cardiac remodeling. Use of loop diuretics may represent a pragmatic, low-cost, and low-burden strategy to improve outcomes in people receiving HD. Lack of data on optimal furosemide dosing, safety, and acceptability are barriers to expanded use. This study investigates whether oral furosemide is safe and effective at increasing urine volume in HD patients.

Timeline

Start
2020-10-07
Primary completion
2021-06-08
Completion
2021-06-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Furosemide Other / unclassified Oral